在伊朗扩大免疫规划中纳入腮腺炎疫苗接种之前的腮腺炎血清流行率。

Seroprevalence of mumps before inclusion of mumps vaccination in the Iranian expanded programme on immunization.

作者信息

Avijgan M, Habibian R, Kheiri S

机构信息

Department of Infectious and Tropical Diseases and Iranian Traditional Medicine Research Centre, Isfahan University of Medical Sciences, Isfahan, Islamic Republic of Iran.

出版信息

East Mediterr Health J. 2009 Mar-Apr;15(2):295-301.

PMID:19554975

Abstract

The current target groups for measles, mumps and rubella vaccination in the Islamic Republic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalenceRepublic of Iran are children at 12 months and 4-6 years. A study of the age-specific seroprevalence of antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the needof antibodies against mumps in children aged 3-18 years in Shahrekord aimed to establish the need for booster vaccinations to cover non-immune children. Of 338 children, 19.8% were seronegative. Age-specific seronegativity was 33.3%, 20.5% and 4.6% in age groups 7-11, 12-14 and 15-18 years respectively. To obtain herd immunity, we suggest that for the next 5 years children aged 7-11 years entering guidance school are selected as the main group for vaccination.

摘要

伊朗伊斯兰共和国目前麻疹、腮腺炎和风疹疫苗的接种目标群体是12个月大以及4至6岁的儿童。一项针对设拉子3至18岁儿童腮腺炎抗体年龄特异性血清阳性率的研究，旨在确定对未免疫儿童进行加强免疫接种的必要性。在338名儿童中，19.8%为血清阴性。7至11岁、12至14岁以及15至18岁年龄组的年龄特异性血清阴性率分别为33.3%、20.5%和4.6%。为了获得群体免疫，我们建议在未来5年将进入指导学校的7至11岁儿童选为主要接种群体。